The Journal of surgical research · 2026
Hypertensive Disorders of Pregnancy and Future Peripheral Vascular Disease.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Levasseur Sophie, Bergeron Ariane, Leite Guedes Idrys Henrique, Wells Sarah, Orcese Benjamin, Pacheco Christine, Malhamé Isabelle, Drudi Laura M
Аннотация
INTRODUCTION: Hypertensive disorders of pregnancy (HDP) are major contributors to maternal morbidity and mortality, with established links to cardiovascular disease. However, the relationship between HDP and peripheral arterial disease (PAD) is poorly defined. This review summarizes available literature on PAD risk following HDP, outlines proposed mechanistic pathways, and identifies key research gaps.
METHODS: A PubMed search identified studies published between 2014 and April 2024 examining HDP and subsequent vascular outcomes. Titles and abstracts were screened for relevance to PAD, and findings were synthesized to highlight risk estimates, mechanisms, and areas requiring further investigation.
RESULTS: Of the 173 identified articles, most addressed cardiovascular disease, with only five specifically evaluating PAD. Evidence on PAD risk is sparse, and definitions and methodologies vary widely across studies. Proposed mechanisms include structural vascular changes, inflammation, impaired angiogenesis, and metabolic disturbances, all converging on a persistent endothelial dysfunction as the final common pathway that may predispose to PAD.
CONCLUSIONS: HDP may be a marker of long-term PAD risk, but current data are limited. Standardized outcome definitions, mechanistic biomarker studies, and PAD-specific cohort analyses are needed to clarify this relationship. Early postpartum surveillance of metabolic and vascular risk factors in women with prior HDP may provide opportunities for timely intervention. This review emphasizes the underrecognized association between HDP and PAD and outlines priorities for future research.
METHODS: A PubMed search identified studies published between 2014 and April 2024 examining HDP and subsequent vascular outcomes. Titles and abstracts were screened for relevance to PAD, and findings were synthesized to highlight risk estimates, mechanisms, and areas requiring further investigation.
RESULTS: Of the 173 identified articles, most addressed cardiovascular disease, with only five specifically evaluating PAD. Evidence on PAD risk is sparse, and definitions and methodologies vary widely across studies. Proposed mechanisms include structural vascular changes, inflammation, impaired angiogenesis, and metabolic disturbances, all converging on a persistent endothelial dysfunction as the final common pathway that may predispose to PAD.
CONCLUSIONS: HDP may be a marker of long-term PAD risk, but current data are limited. Standardized outcome definitions, mechanistic biomarker studies, and PAD-specific cohort analyses are needed to clarify this relationship. Early postpartum surveillance of metabolic and vascular risk factors in women with prior HDP may provide opportunities for timely intervention. This review emphasizes the underrecognized association between HDP and PAD and outlines priorities for future research.